Slide 1: Investor Presentation June 2011
For personal use only Investor Presentation June 2011 DISCLAIMER The release, publication or distribution of this presentation in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this presentation is released, published or distributed should infor
Slide 2: Introduction and Company Overview
INTRODUCTION For personal use only Clover Corporation Limited provides nutritional and functional ingredients for use in infant formula, foods and specialty applications using proprietary technology. Future Food Ingredients (100%) (50%) COMPANY OVERVIEW • Mission is to identify, develop and commerci
Slide 3: Summary of Financial Performance FY2010
SUMMARY OF FINANCIAL PERFORMANCE FY2010 For personal use only FY2010 FY2009 Shares on issue 165.2 million 165.2 million Total contributed equity $32.9 million $32.9 million Market capitalization $49.6 million (# as at 9/9/10) $32.2 million (as at 23/11/09) Cash at year end $12.1 million $9.2 million
Slide 4: Summary of Financial Performance FH FY2011; FFI Progress on Closure & Sale
SUMMARY OF FINANCIAL PERFORMANCE FH FY2011 For personal use only FH FY2011 FH FY2010 Market capitalization $47.9 million (# as at 8/5/11) $49.6 million (as at 9/9/10) Cash at half year $9.2 million $8.1 million Sales Revenue at half $14.0 million $16.4 million year Net Profit for half year $1.95 mil
Slide 5: Nu-Mega Ingredients Pty Ltd Overview
For personal use only 9 NU-MEGA INGREDIENTS PTY LTD Overview • Australian producer & international supplier of microencapsulated powders. • Encapsulation processes are patented in many countries. • Specialties include omega-3 & omega-6 oils (marine & algal sources). • Process protects oil from oxida
Slide 6: FH FY11 Key Milestones for Nu-Mega Ingredients
FH FY11 KEY MILESTONES FOR NU-MEGA INGREDIENTS For personal use only • Consolidate exceptional sales growth experienced in FY10. – Anticipated sales revenue to be between $32.5 million and $33.0 million. • Continued growth of sales in Asia. • Expansion of product range to meet customer requirements,
Slide 7: Focus on the Growth Markets
FOCUS ON THE GROWTH MARKETS For personal use only GOED Frost & Sullivan Report 2011 • Global market for marine and algal EPA & DHA ingredients approx. $1.5 billion (2009). • Asia-Pacific represented 25% of the market (i.e. USD$363.5m in 2009). • Global infant nutrition represented 3,103 MT (in 2009)
Slide 8: Segments of the Infant Formula Market Using DHA
SEGMENTS OF THE INFANT FORMULA MARKET USING DHA For personal use only Infant formula market • Tuna oil has a DHA: EPA ratio similar to human breast milk unlike other fish. • Infant Formula markets are divided into four product ranges – Starting, Follow On, Toddler and Special. • These products are p
Slide 9: Overview of Nu-Mega Products
OVERVIEW OF NU-MEGA PRODUCTS For personal use only Tuna oil Algal & other oils Other bioactives Refine Purchase from various sources Emulsion Tuna oil Microencapsulated Powders 17 THE IMPORTANCE OF NU-MEGA MICROENCAPSULATION Protects lipids against oxidation Protects against undesirable changes
Slide 10: Innovation Program
INNOVATION PROGRAM For personal use only TECH 1 (OWNED) ENCAPSULATION Omega 3 lipids Infant formula TECH 2 (LICENSED) ENCAPSULATION Omega 3 &/or 6 lipids Infant formula / Functional foods Infant formula / TECH 3 (LICENSED) ENCAPSULATION Omega 3 &/or 6 lipids Functional foods / Medical foods TECH 4 (
Slide 11: Sponsored Research 2008-2011 / Outlook 2012
SPONSORED RESEARCH IN 2008 - 2011 For personal use only 21 21 Outlook 2012 Clover Corporation 22 11
Slide 12: Outlook FY2012
OUTLOOK FY2012 For personal use only • Return to sales growth with the commercial adoption of new products. • Continued expansion of the R&D program. • Continued strong sales of ingredients for infant formula, infant nutrition & foods for children. • Revitalize sales & distribution in the Americas a